Navigation Links
NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
Date:9/22/2009

on, including its most recent Quarterly Report on Form 10-Q. Actual results could differ materially from the forward-looking statements contained in this press release. Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
2. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
3. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
4. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
5. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
6. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
7. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
8. Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
9. In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
10. Sanofi Aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
11. Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...AMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCal...HIN),aleadinginnovatorandprovideroflessinvasive,mi...izingthetreatmentofadvancedheartfailure,todayannou...tthe21stAnnualPiperJaffrayHealthCareConferenceat8:...eingheldattheNewYorkPalaceHotel,December1-2. ,,...
(Date:11/24/2009)...DISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiag...roviderofdiagnostictesting,informationandservices,...perJaffrayHealthcareConferenceinNewYorkCity.Thepre...:30a.m.EasternTime. ,, Duringtheconference,thec...oapproximate3%,operatingincometoexceed18%ofrevenue...
(Date:11/24/2009)...EASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Thor...e-basedmechanicalcirculatorysupporttherapiestosave...lbeparticipatinginthe21stAnnualPiperJaffrayHealthC...th,executivevicepresidentandchieffinancialofficer,....,EasternStandardTime(5:30a.m.,PacificStandardTime...
Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 1Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 2Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 3Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 4Access Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 52416 1Access Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 52416 2Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 1Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 2
(Date:11/25/2009)...ingTogethertoShareRecordsSafely,ImproveCare ,...artmentofVeteransAffairs(VA)andKaiserPermanentetod...ndservicestoourNation,sheroes.VAandKaiserPermanent...threcord(EHR)informationusingtheNationwideHealthIn...thandHumanServices. ,, "Theabilitytosharecritic...
(Date:11/25/2009)...KECITY,Nov.25/PRNewswire/--dazzlesmile,llc www.daz...alhealthscience.com havefileda67-pagefederallawsui...,Inc.,JesseWillms,FarendServicesLimited,andAtLastF...StatesDistrictCourtfortheDistrictofUtah,allegesmas...ile(TM)brandedteethwhiteningproducts,violationsoft...
(Date:11/25/2009)...RA,Fla.,Nov.25/PRNewswire/--DanielTouizer,CEOof C...teedissuehealthinsurancebenefitprograms,isconcerne...meansnearlyoneinfiveAmericansarewithoutafull-timej...mploymentratesaredeterminedbytheU-6number,whichhas...ani e l T ouizer ."Thesestatisticsarealarming...
(Date:11/25/2009)...Two signaling pathways essential to normal human d...growth factor receptor (EGFR) pathways - interact ...etastasis, researchers from The University of Texa...25 issue of Molecular Cell . , This newly chara...onents known to correlate with invasive cancer - a...
(Date:11/25/2009)... - The American Society of,Hematology (ASH) is pl...rs with,the highest scoring abstracts in the cate... graduate student, resident physician, and post-do... honorarium plus annual meeting,travel reimbursem... Undergraduate,Student , Kimberly Fan , Donor...
Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:ASH announces 2009 Merit Award winners 2
...ganization, CINCINNATI, May 27 Berkeley Premium ...fficulties and seeing positive results.,Consumers ... and at retail., Despite the recent economic down...ct launches and more aggressive,recruiting., Thro...
... infrastructure for MRF,s collaborative ...f., May 27 Collaborative Drug,Discovery, Inc. (CD...ich,organizes preclinical research data to help sc...aborate more,effectively., MRF,s Accelerated Rese...
...(TM), An Organic First For Children,s ... May 27 While whole food,chemical-free nutrition ...nt, parents have had a singular choice with childr...od complexed vitamins and supplements -- gives par...
...py with simple series of head, body movements to c...News) -- The best treatment for vertigo is the eas... Academy of Neurology guideline. , The guideline...series of head and body movements performed by a d...
... Corporation,(Nasdaq: SMTS ) announced today that...od and Drug Administration (FDA) to expand the lab...em., "We believe this new 510(k) will serve to su...t, the 510(k) expands,the indication for use to in...
... the nation,s,largest pharmacy benefits management...nnsylvania and 28 other states resolving claims of...Tom Corbett said the agreement was reached with,Ex...s is required to change its,business practices and...
Other Medicine News:Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 2Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 4Health News:Finally ... A Pure and Perfect Multi-Vitamin for Every Kid 2Health News:Finally ... A Pure and Perfect Multi-Vitamin for Every Kid 3Health News:Best Treatment for Vertigo Is Easiest One 2Health News:Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc. 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc. 3
Sterile Coil Packed Pediatric Suction Catheters with SAFE-T-VAC Valve
Sterile Suction Catheters without Control Valve
Sterile Single Loop Suction Catheters with TOUCH-TROL Valve
Catheter Suction 14FR Sterile W/Control Valve
Medicine Products: